{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:35:34Z","timestamp":1772084134689,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Qatar National Library"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Cystic fibrosis is a genetic disorder caused by a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene defect. Many across the globe suffer the debilitating symptoms. The aim of this commentary is to briefly cover various aspects related to the disease in the Arab world and then in Qatar.<\/jats:p>","DOI":"10.3390\/jpm13030448","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T02:28:17Z","timestamp":1677637697000},"page":"448","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in Cystic Fibrosis Research in Qatar: A Commentary"],"prefix":"10.3390","volume":"13","author":[{"given":"Samer","family":"Hammoudeh","sequence":"first","affiliation":[{"name":"Research Affairs, Academic Health System, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-7362","authenticated-orcid":false,"given":"Ibrahim A.","family":"Janahi","sequence":"additional","affiliation":[{"name":"Medical Education, Sidra Medicine, Doha P.O. Box 26999, Qatar"},{"name":"Pediatric Pulmonology, Pediatric Medicine, Sidra Medicine, Doha P.O. Box 26999, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"eS8","DOI":"10.1016\/S0929-693X(20)30044-0","article-title":"CFTR gene variants, epidemiology and molecular pathology","volume":"27","author":"Bareil","year":"2020","journal-title":"Arch. P\u00e9diatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: A disease with a new face","volume":"109","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ramalho, S.S., Silva, I.A.L., Amaral, M.D., and Farinha, C.M. (2021). Rare Trafficking CFTR Mutations Involve Distinct Cellular Retention Machineries and Require Different Rescuing Strategies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010024"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: Advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_6","unstructured":"(2023, February 22). The Clinical and Functional TRanslation of CFTR (CFTR2). Available online: https:\/\/cftr2.org\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpam.2015.05.006","article-title":"The road for survival improvement of cystic fibrosis patients in Arab countries","volume":"2","author":"Banjar","year":"2015","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.jcf.2018.12.002","article-title":"Letter to the editor: Cystic fibrosis in the Middle East: An awareness analysis","volume":"18","author":"Hider","year":"2019","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s42399-021-00756-z","article-title":"The Epidemiology of Cystic Fibrosis in Arab Countries: A Systematic Review","volume":"3","author":"Hammoudeh","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/resp.13437","article-title":"Spectrum of mutations of cystic fibrosis in the 22 Arab countries: A systematic review","volume":"24","author":"Abunada","year":"2019","journal-title":"Respirology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40248-019-0193-4","article-title":"Approaching two decades of cystic fibrosis research in Qatar: A historical perspective and future directions","volume":"14","author":"Hammoudeh","year":"2019","journal-title":"Multidiscip. Respir. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40142-019-00174-7","article-title":"An Overview of the Homozygous Cystic Fibrosis Transmembrane Conductance Regulator Mutation c.3700 A>G (p.Ile1234Val) in Qatar","volume":"7","author":"Hammoudeh","year":"2019","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/tropej\/47.2.110a","article-title":"Heterogeneity of the Cystic Fibrosis Phenotype in a Large Kindred Family in Qatar with Cystic Fibrosis Mutation (I1234V)","volume":"47","author":"Wahab","year":"2001","journal-title":"J. Trop. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5339\/qmj.2021.24","article-title":"First report of the cystic fibrosis transmembrane conductance regulator mutation c.1521_1523delCTT (p. Phe508del) in two Qatari patients with cystic fibrosis","volume":"2021","author":"AbdulWahab","year":"2021","journal-title":"Qatar Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/tropej\/50.4.242","article-title":"Pseudo-Bartter\u2019s Syndrome in an Egyptian Infant with Cystic Fibrosis Mutation N1303K","volume":"50","author":"Wahab","year":"2004","journal-title":"J. Trop. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/tropej\/50.2.120","article-title":"Rare CFTR Mutation 1525-1G) A in a Pakistani Patient","volume":"50","author":"Wahab","year":"2004","journal-title":"J. Trop. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02724936.2000.11748135","article-title":"Cystic fibrosis in a large kindred family in Qatar","volume":"20","author":"Wahab","year":"2000","journal-title":"Ann. Trop. Paediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1080\/08035250500538981","article-title":"Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation","volume":"95","author":"Rahman","year":"2006","journal-title":"Acta Paediatr."},{"key":"ref_19","first-page":"A5518","article-title":"Baseline exhaled nitric oxide level in cystic fibrosis patients with I1234V mutation is lower than normal and affected by gender and airway microbiome","volume":"Volume 189","author":"Saadoon","year":"2014","journal-title":"D25 Pediatric Cystic Fibrosis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/tropej\/50.4.229","article-title":"Microbiological Identification in Cystic Fibrosis Patients with CFTR I1234V Mutation","volume":"50","author":"Wahab","year":"2004","journal-title":"J. Trop. Pediatr."},{"key":"ref_21","first-page":"e15948","article-title":"Sputum and Plasma Neutrophil Elastase in Stable Adult Patients With Cystic Fibrosis in Relation to Chronic Pseudomonas Aeruginosa Colonization","volume":"13","author":"AbdulWahab","year":"2021","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mgg3.474","article-title":"Clinical genetics and genomic medicine in Qatar","volume":"6","author":"Shahbeck","year":"2018","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cabral, B., Terlizzi, V., Laselva, O., Conte Filho, C., and Mota, F. (2022). Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051283"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/S1569-1993(14)60417-3","article-title":"282 Patient priorities for research in cystic fibrosis: The IPaCOR experience","volume":"13","author":"Cirilli","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fphar.2018.00396","article-title":"Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique","volume":"9","author":"Marangi","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/2050640616670565","article-title":"Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis","volume":"5","author":"Hohwieler","year":"2017","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1083\/jcb.201610056","article-title":"Organoids: A historical perspective of thinking in three dimensions","volume":"216","author":"Simian","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Li, L., and Somerset, S. (2018). Associations between flavonoid intakes and gut microbiota in a group of adults with cystic fibrosis. Nutrients, 10.","DOI":"10.3390\/nu10091264"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1165\/rcmb.2009-0281OC","article-title":"Activation of the Cystic Fibrosis Transmembrane Conductance Regulator by the Flavonoid Quercetin","volume":"43","author":"Pyle","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/3\/448\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:44:35Z","timestamp":1760121875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/13\/3\/448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jpm13030448"],"URL":"https:\/\/doi.org\/10.3390\/jpm13030448","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}